S&P ASX All Technology

US Dollar vs AUD

Register to chat with like-minded investors on our interactive forums.

Get Started

ABVC ABVC BioPharma Inc

1.01

-0.04 (-3.81%)

20 Apr 2024 - Closed

Delayed by 15 minutes

ABVC Biopharma introduces dietary supplements, signs exclusive distribution deal

To read the full story on Seeking Alpha, click here.

ABVC BioPharma (NASDAQ:ABVC)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more ABVC BioPharma Charts.

ABVC BioPharma (NASDAQ:ABVC)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more ABVC BioPharma Charts.

ABVC BioPharma Inc News

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Thursday 18 April 2024 (2 days ago) • GlobeNewswire Inc.

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Wednesday 17 April 2024 (3 days ago) • GlobeNewswire Inc.

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Wednesday 10 April 2024 (1 week ago) • GlobeNewswire Inc.

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Tuesday 26 March 2024 (4 weeks ago) • GlobeNewswire Inc.

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
Tuesday 19 March 2024 (1 month ago) • GlobeNewswire Inc.

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Friday 15 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Saturday 17 February 2024 (2 months ago) • Edgar (US Regulatory)

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
Friday 16 February 2024 (2 months ago) • GlobeNewswire Inc.

More ABVC BioPharma Inc News Articles

Westpac Banking

AUD vs US Dollar

Newcrest Mining

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions